secwatch.observer — SEC 8-K summary
======================================

Issuer:     INVO Fertility, Inc. (IVF)
CIK:        0001417926
Form:       8-K
Filed at:   2023-02-23T23:59:59+00:00
Accession:  0001493152-23-005872
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INVO Bioscience issues $200K convertible debenture at 8% interest, with warrants and commitment shares
--------------------------------------------------------------------------------

- Issued $200,000 convertible debenture to Firstfire Global Opportunities Fund at $180,000 purchase price (10% OID).
- Debenture carries 8% annual interest, matures Feb 17, 2024; convertible at $0.52 per share initially.
- Also issued warrant to buy 100,000 shares at $0.75 and 33,333 commitment shares as inducement.
- Proceeds used for working capital; placement agent fee $14,400.
- Exchange cap of 2,436,045 shares (19.99% of outstanding) unless shareholder approval obtained.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417926/000149315223005872/0001493152-23-005872-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417926/000149315223005872/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-005872

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer